ES450520A1 - Procedimiento para la obtencion de soluciones solubilizablesy estabilizadas de 2-cloro-11-(4-metil-i-piperazinil)-dibenz(b,f) (1,4) oxazepina. - Google Patents
Procedimiento para la obtencion de soluciones solubilizablesy estabilizadas de 2-cloro-11-(4-metil-i-piperazinil)-dibenz(b,f) (1,4) oxazepina.Info
- Publication number
- ES450520A1 ES450520A1 ES450520A ES450520A ES450520A1 ES 450520 A1 ES450520 A1 ES 450520A1 ES 450520 A ES450520 A ES 450520A ES 450520 A ES450520 A ES 450520A ES 450520 A1 ES450520 A1 ES 450520A1
- Authority
- ES
- Spain
- Prior art keywords
- solution
- oxazepine
- hydrochloric acid
- administratio
- parental
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Procedimiento para la obtención de soluciones solubilizables y estabilizadas de 2-cloro-ll-84-metil-I- piperizanil)9dibenz [b,f] [1,4] oxazepina o una sal farmaceúticamente aceptable de la misma, caracterizado porque comprende disolver dicha oxazepina o su sal en aproximadamente 50% y 80% en volúmenes de solución acuosa de propilenolicol, ajustar el pH a aproximadamente 5,0 hasta aproximadamente 7,0 con ácido clorhídrico a 10%, calentar la solución a 60ºC durante 30 minutos, enfriar la solución a temperatura ambiente, reajustar el pH entre 5,0 y 7,0 aproximadamente con ácido clorhídico a 10%, diluir la solución a 100 por 100% con agua, filtrar la solución para eliminar las partículas sólidas, esterilizar con refiltrado la solución a través de una membrana resistente al disolvente de 0,2 a 1,2 micras para obtener una solución final que tiene una potencia de 2,0% a 5,0% de ingrediente activo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60233175A | 1975-08-06 | 1975-08-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES450520A1 true ES450520A1 (es) | 1978-05-01 |
Family
ID=24410918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES450520A Expired ES450520A1 (es) | 1975-08-06 | 1976-08-06 | Procedimiento para la obtencion de soluciones solubilizablesy estabilizadas de 2-cloro-11-(4-metil-i-piperazinil)-dibenz(b,f) (1,4) oxazepina. |
Country Status (19)
Country | Link |
---|---|
JP (1) | JPS5221313A (es) |
AR (1) | AR210501A1 (es) |
AT (1) | AT345464B (es) |
AU (1) | AU500641B2 (es) |
BE (1) | BE844903A (es) |
CA (1) | CA1069823A (es) |
DE (1) | DE2633943A1 (es) |
DK (1) | DK147727C (es) |
EG (1) | EG12425A (es) |
ES (1) | ES450520A1 (es) |
FI (1) | FI762171A (es) |
FR (1) | FR2320102A1 (es) |
GB (1) | GB1546933A (es) |
IL (1) | IL49996A (es) |
NL (1) | NL7608575A (es) |
NO (1) | NO146457C (es) |
PT (1) | PT65400B (es) |
SE (1) | SE431716B (es) |
ZA (1) | ZA764052B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2739254B1 (fr) * | 1995-09-29 | 1997-12-19 | Rhone Merieux | Composition antiparasitaire pour le traitement et la protection des animaux de compagnie |
FR2739255B1 (fr) * | 1995-09-29 | 1998-09-04 | Rhone Merieux | Composition antiparasitaire pour le traitement et la protection des animaux de compagnie |
IE80657B1 (en) * | 1996-03-29 | 1998-11-04 | Merial Sas | Insecticidal combination to control mammal fleas in particular fleas on cats and dogs |
WO2010106325A2 (en) | 2009-03-18 | 2010-09-23 | Omnipharm Limited | Parasiticidal formulation |
-
1976
- 1976-07-02 CA CA256,154A patent/CA1069823A/en not_active Expired
- 1976-07-07 ZA ZA764052A patent/ZA764052B/xx unknown
- 1976-07-08 IL IL49996A patent/IL49996A/xx unknown
- 1976-07-09 GB GB28752/76A patent/GB1546933A/en not_active Expired
- 1976-07-09 AU AU15775/76A patent/AU500641B2/en not_active Expired
- 1976-07-13 AR AR263933A patent/AR210501A1/es active
- 1976-07-22 PT PT65400A patent/PT65400B/pt unknown
- 1976-07-28 DE DE19762633943 patent/DE2633943A1/de not_active Withdrawn
- 1976-07-29 FI FI762171A patent/FI762171A/fi not_active Application Discontinuation
- 1976-08-02 NL NL7608575A patent/NL7608575A/xx not_active Application Discontinuation
- 1976-08-04 EG EG475/76A patent/EG12425A/xx active
- 1976-08-05 SE SE7608810A patent/SE431716B/xx unknown
- 1976-08-05 FR FR7623990A patent/FR2320102A1/fr not_active Withdrawn
- 1976-08-05 DK DK354076A patent/DK147727C/da not_active IP Right Cessation
- 1976-08-05 AT AT581376A patent/AT345464B/de not_active IP Right Cessation
- 1976-08-05 NO NO762713A patent/NO146457C/no unknown
- 1976-08-05 BE BE169573A patent/BE844903A/xx not_active IP Right Cessation
- 1976-08-06 JP JP51093257A patent/JPS5221313A/ja active Pending
- 1976-08-06 ES ES450520A patent/ES450520A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
PT65400B (en) | 1978-01-27 |
JPS5221313A (en) | 1977-02-17 |
DE2633943A1 (de) | 1977-02-17 |
NO762713L (es) | 1977-02-08 |
AT345464B (de) | 1978-09-25 |
SE431716B (sv) | 1984-02-27 |
NO146457B (no) | 1982-06-28 |
CA1069823A (en) | 1980-01-15 |
GB1546933A (en) | 1979-05-31 |
AR210501A1 (es) | 1977-08-15 |
NL7608575A (nl) | 1977-02-08 |
FR2320102A1 (fr) | 1977-03-04 |
IL49996A (en) | 1981-01-30 |
IL49996A0 (en) | 1976-09-30 |
PT65400A (en) | 1976-08-01 |
AU500641B2 (en) | 1979-05-31 |
EG12425A (en) | 1979-06-30 |
ATA581376A (de) | 1978-01-15 |
DK354076A (da) | 1977-02-07 |
BE844903A (fr) | 1977-02-07 |
ZA764052B (en) | 1977-06-29 |
NO146457C (no) | 1982-10-06 |
FI762171A (es) | 1977-02-07 |
SE7608810L (sv) | 1977-02-07 |
DK147727C (da) | 1985-06-17 |
DK147727B (da) | 1984-11-26 |
AU1577576A (en) | 1978-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO971986D0 (no) | Fremgangsmåte for fremstilling av små partikler | |
PE20090124A1 (es) | Composicion farmaceutica que comprende cristales de aripiprazol b de baja higroscopicidad y procedimiento de preparacion de la misma | |
SG48087G (en) | Orally administrable antidiabetic compositions | |
ES2064887T3 (es) | Composiciones quimicas solidas estabilizadas. | |
ES462065A1 (es) | Procedimiento para la preparacion de derivados de tiazolidi-na. | |
HU171226B (hu) | Insekticidnye, akaricidnye i fungicidnye kompozicii, i sposob poluchenija proizvodnykh amidokarbonil-tiobarbiturovojj kisloty i soli primenimykh aktivnymi agentami | |
NO870962L (no) | Fremgangsmaate for fremstilling av dermatan-sulfat av hoey renhet. | |
ES450520A1 (es) | Procedimiento para la obtencion de soluciones solubilizablesy estabilizadas de 2-cloro-11-(4-metil-i-piperazinil)-dibenz(b,f) (1,4) oxazepina. | |
IL49391A (en) | 6-chloro-2-(1-piperazinyl)pyrazine and acid addition salts, their preparation and pharmaceutical compositions containing them | |
SE7707689L (sv) | 2-brom-6-fluor-n-2-imidazolidinylidenbensamin dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav | |
ES455691A1 (es) | Procedimiento para la produccion de derivados de piperacina. | |
SE7811455L (sv) | 2-imino-imidazolidin-derivat | |
ES388882A1 (es) | Procedimiento para la preparacion de 1-(2-nitrilofenoxi)-2-hidroxi-3-etilaminopropano racemicos u opticamente activo. | |
NL190371C (nl) | Cycloalkanonoximethers met therapeutische eigenschappen en zuuradditiezouten en quaternaire ammoniumderivaten daarvan, alsmede farmaceutische samenstellingen, die deze verbindingen bevatten, en werkwijze voor de bereiding van de verbindingen. | |
PE20010209A1 (es) | Polimorfos de un citrato de azobiciclo[2,2,2] octan-3-amina y sus composiciones farmaceuticas | |
NO872574L (no) | Fremgangsmte for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler. | |
SE7906681L (sv) | Ftalazonderivat | |
JPS5289629A (en) | Dopamine derivatives and medicaments containing the same | |
ES8300747A1 (es) | Procedimiento para la preparacion de derivados de acido in- dolacetico | |
JPS525769A (en) | Preparation of 3-substituted pyrolidine derivatives | |
JPS5278887A (en) | Synthesis of n-(2-tetrahydrofuryl)-5-fluorouracil | |
NO176179C (no) | Analogifremgangsmåte for fremstilling av nye terapeutisk aktive 2-substituerte N,N'-di(trimetoksybenzoyl)piperaziner | |
JPS5251378A (en) | Preparation of 4(3h)-quinazolinone derivatives | |
NL7705642A (nl) | Werkwijze ter bereiding van derivaten van 6'-ami- no-spiro(cycloalkaan-1,2'-penam)-3'-carbonzuur. | |
IE44457L (en) | Alkyleneidioxybenzylpiperazine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19991007 |